Semaglutide

Brand name: Ozempic, Wegovy

D

Score D — Possible Hepatotoxin

Single case reports have appeared implicating this drug, but the evidence is limited.

Fewer than 3 cases have been reported in the literature. No characteristic signature has been identified, and the case reports may not have been very convincing.

Primary class Endocrine
Secondary class Diabetes, Weight Loss
FDA approval 2017